Emirates News Agency on MSN3d
DoH introduces advanced gene-editing therapy for sickle cell disease, thalassemia for first time in UAEThe Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the introduction of CASGEVY, the first CRISPR/Cas9 gene-editing therapy in the UAE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback